Evidence map›Paper›PMID 35491840›Full record

ArticleJournal of clinical microbiology2022

Diagnosis of Congenital Toxoplasmosis: No Benefit of IgA Antibody Detection by Platelia ELISA in a Tricentric Evaluation.

Maude F Lévêque, Sahar Albaba, Neïla Arrada, Marine Avignon, Milène Sasso, Judith Fillaux, Laurence Lachaud

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Maude F LévêqueUniversité de Montpellier, Centre National de la Recherche Scientifique, IRD, UMR MiVEGEC, Montpellier, France.
Sahar AlbabaDépartement de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Neïla ArradaDépartement de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Marine AvignonService de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Milène SassoUniversité de Montpellier, Centre National de la Recherche Scientifique, IRD, UMR MiVEGEC, Montpellier, France.ORCID 0000-0002-6539-8545
Judith FillauxService de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Laurence LachaudUniversité de Montpellier, Centre National de la Recherche Scientifique, IRD, UMR MiVEGEC, Montpellier, France.
Université de Montpellier · FRCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire de Toulouse · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnostic accuracy of a commercial Toxoplasma gondii IgA antibody enzyme-linked immunosorbent assay (ELISA) was evaluated in the context of routine practice on 289 newborns with congenital toxoplasmosis (CT) and 220 healthy controls. The performance of this assay was compared to that of the current gold-standard test for anti-

Indexed as

ToxoplasmaToxoplasmosisToxoplasmosis, CongenitalAntibodies, ProtozoanEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin AImmunoglobulin MInfant, NewbornAntibodies, ProtozoanImmunoglobulin AImmunoglobulin MIgMimmunodiagnosismaternal seroconversionnewbornspostnatal diagnosisToxoplasma gondii

Identifiers

PMID35491840
PMCPMC9116159
OpenAlexW4225281566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.